In addition, we analyzed SREBP1 and FABP4 mRNA expressions and discovered them to be associated with the expression of genes participating in lipid storage, hepatic steatosis, hepatic lipogenesis, and NAFLD pathogenesis [33,53]. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.